This section shows a summary for the selected study (COSU identifier) or publication (COSP identifier). Studies may have been performed by the Sanger Institute Cancer Genome Project, or imported from the ICGC/TCGA. You can see more information on the help pages.
- Reference
- Genetic alterations activating kinase and cytokine receptor signaling in high-risk acute lymphoblastic leukemia.
- Paper ID
- COSP29664
- Authors
- Affiliation
- Department of Pathology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.
- Journal
-
Cancer cell, 2012;22(2):153-66
ISSN: 1878-3686
PMID: 22897847 (view at PubMed or Europe PMC) - Abstract
- Genomic profiling has identified a subtype of high-risk B-progenitor acute lymphoblastic leukemia (B-ALL) with alteration of IKZF1, a gene expression profile similar to BCR-ABL1-positive ALL and poor outcome (Ph-like ALL). The genetic alterations that activate kinase signaling in Ph-like ALL are poorly understood. We performed transcriptome and whole genome sequencing on 15 cases of Ph-like ALL and identified rearrangements involving ABL1, JAK2, PDGFRB, CRLF2, and EPOR, activating mutations of IL7R and FLT3, and deletion of SH2B3, which encodes the JAK2-negative regulator LNK. Importantly, several of these alterations induce transformation that is attenuated with tyrosine kinase inhibitors, suggesting the treatment outcome of these patients may be improved with targeted therapy.
- Paper Status
- Curated